103 related articles for article (PubMed ID: 7049340)
1. Oral lecithin and linoleic acid in Friedreich's ataxia: I. Design of the study, material and methods.
Melancon SB; Dallaire L; Potier M; Vanasse M; Marois P; Geoffroy G; Barbeau A
Can J Neurol Sci; 1982 May; 9(2):151-4. PubMed ID: 7049340
[TBL] [Abstract][Full Text] [Related]
2. Oral lecithin and linoleic acid in Friedreich's ataxia: II. Clinical results.
Melancon SB; Vanasse M; Geoffroy G; Barabe L; Proulx A; Fontaine G; Dallaire L; Potier M
Can J Neurol Sci; 1982 May; 9(2):155-64. PubMed ID: 7049341
[TBL] [Abstract][Full Text] [Related]
3. Oral lecithin and linoleic acid in Friedreich's ataxia: III. Biochemical results.
Melancon SB; Dallaire L; Potier M; Cousineau J; Vanasse M; Geoffroy G; Fontaine G; Grignon B
Can J Neurol Sci; 1982 May; 9(2):165-9. PubMed ID: 6896672
[TBL] [Abstract][Full Text] [Related]
4. Lecithin treatment in Friedreich's ataxia.
Pentland B; Martyn CN; Steer CR; Christie JE
Br Med J (Clin Res Ed); 1981 Apr; 282(6271):1197-8. PubMed ID: 6788133
[No Abstract] [Full Text] [Related]
5. A six-month phosphatidylcholine trial in Friedreich's ataxia.
Filla A; Campanella G
Can J Neurol Sci; 1982 May; 9(2):147-50. PubMed ID: 7104881
[TBL] [Abstract][Full Text] [Related]
6. Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia.
Zesiewicz T; Heerinckx F; De Jager R; Omidvar O; Kilpatrick M; Shaw J; Shchepinov MS
Mov Disord; 2018 Jul; 33(6):1000-1005. PubMed ID: 29624723
[TBL] [Abstract][Full Text] [Related]
7. Effect of lecithin on disability and plasma free-choline levels in Friedreich's ataxia.
Chamberlain S; Robinson N; Walker J; Smith C; Benton S; Kennard C; Swash M; Kilkenny B; Bradbury S
J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):843-5. PubMed ID: 7420107
[TBL] [Abstract][Full Text] [Related]
8. Correlation between serum lipoamide dehydrogenase activity and phosphatidylcholine therapy in Friedreich's ataxia.
Melançon SB; Fontaine G; Geoffroy G; Vanasse M; Dallaire L; Potier M
Can J Neurol Sci; 1980 Nov; 7(4):413-6. PubMed ID: 6894263
[TBL] [Abstract][Full Text] [Related]
9. [Lecithin therapy of hereditary ataxia].
Trizio M; Pozio G; Margari L; Massagli A; Serlenga L
Riv Patol Nerv Ment; 1983; 104(2):49-59. PubMed ID: 6679921
[TBL] [Abstract][Full Text] [Related]
10. A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia.
Filla A; De Michele G; Orefice G; Santorelli F; Trombetta L; Banfi S; Squitieri F; Napolitano G; Puma D; Campanella G
Can J Neurol Sci; 1993 Feb; 20(1):52-5. PubMed ID: 8467430
[TBL] [Abstract][Full Text] [Related]
11. Strong correlations among four measures of disease progression in Friedreich's ataxia.
Saal HJ; Heerinckx F; Zawadzki R; Omidvar O; Kilpatrick M; Zesiewicz T
Mov Disord; 2018 Jul; 33(6):1021-1022. PubMed ID: 29624733
[No Abstract] [Full Text] [Related]
12. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study.
Trouillas P; Serratrice G; Laplane D; Rascol A; Augustin P; Barroche G; Clanet M; Degos CF; Desnuelle C; Dumas R
Arch Neurol; 1995 May; 52(5):456-60. PubMed ID: 7733839
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid profile of major lipid classes in plasma lipoproteins of patients with Friedreich's ataxia-demonstration of a low linoleic acid content most evident in the cholesterol-ester fraction.
Davignon J; Huang YS; Wolf JP; Barbeau A
Can J Neurol Sci; 1979 May; 6(2):275-83. PubMed ID: 226259
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia.
Zesiewicz T; Salemi JL; Perlman S; Sullivan KL; Shaw JD; Huang Y; Isaacs C; Gooch C; Lynch DR; Klein MB
Neurodegener Dis Manag; 2018 Aug; 8(4):233-242. PubMed ID: 30051753
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates.
Reisman SA; Gahir SS; Lee CI; Proksch JW; Sakamoto M; Ward KW
Drug Des Devel Ther; 2019; 13():1259-1270. PubMed ID: 31118567
[TBL] [Abstract][Full Text] [Related]
16. Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.
Lynch DR; Mathews KD; Perlman S; Zesiewicz T; Subramony S; Omidvar O; Vogel AP; Krtolica A; Litterman N; van der Ploeg L; Heerinckx F; Milner P; Midei M
J Neurol; 2023 Mar; 270(3):1615-1623. PubMed ID: 36462055
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the effects of acetazolamide in Friedreich's ataxia: a pilot study.
Richards CL; Bouchard JP; Dumas F; Tardif D
Can J Neurol Sci; 1984 Nov; 11(4 Suppl):554-60. PubMed ID: 6509401
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
Bonnet AM; Esteguy M; Tell G; Schechter PJ; Hardenberg J; Agid Y
Can J Neurol Sci; 1986 Nov; 13(4):331-3. PubMed ID: 3465425
[TBL] [Abstract][Full Text] [Related]
19. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Romano S; Coarelli G; Marcotulli C; Leonardi L; Piccolo F; Spadaro M; Frontali M; Ferraldeschi M; Vulpiani MC; Ponzelli F; Salvetti M; Orzi F; Petrucci A; Vanacore N; Casali C; Ristori G
Lancet Neurol; 2015 Oct; 14(10):985-91. PubMed ID: 26321318
[TBL] [Abstract][Full Text] [Related]
20. Lecithin: cholesterol acyltransferase activity and fatty acid composition of erythrocyte phospholipids in Friedreich's ataxia.
Huang YS; Marcel YL; Vezina C; Barbeau A; Davignon J
Can J Neurol Sci; 1980 Nov; 7(4):429-34. PubMed ID: 7214259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
